icone plus
Contact Abonnez-vous aux actualités
Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
R3gW6g2Fn5dRKPtW
Listen
